Stockreport

Myriad Genetics (MYGN) Wins Foundational Patent for MRD Assay [Yahoo! Finance]

Myriad Genetics, Inc.  (MYGN) 
Last myriad genetics, inc. earnings: 2/6 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: myriad.com/news-center/investor-information
PDF ability to deliver a tumor-informed, high-definition, molecular residual disease (MRD) assay to the market. U.S. patent 11,932,910, entitled Combinatorial DNA Screening, [Read more]